TY  - GENERIC
DO  - 10.20944/preprints202404.1119.v1
UR  - http://dx.doi.org/10.20944/preprints202404.1119.v1
TI  - Immunogenicity of the Monovalent Omicron XBB.1.5-Adapted BNT162b2 COVID-19 Vaccine against XBB.1.5, BA.2.86, and JN.1 Sublineages: A Phase 2/3 Trial <strong> </strong>
T2  - Preprints
AU  - Gayed, Juleen
AU  - Bangad, Vishva
AU  - Xu, Xia
AU  - Mensa, Federico
AU  - Cutler, Mark
AU  - Türeci, Özlem
AU  - Şahin, Uǧur
AU  - Modjarrad, Kayvon
AU  - Swanson, Kena A.
AU  - Anderson, Annaliesa S.
AU  - Gurtman, Alejandra
AU  - Kitchin, Nicholas
PY  - 2024
DA  - 2024/04/17
PB  - Preprints